Long-term Outcomes of Adalimumab Therapy in Korean Patients with Ulcerative Colitis: A Hospital-Based Cohort Study

Background/Aims: Studies on long-term outcomes of adalimumab therapy in non-Caucasian patients with ulcerative colitis (UC) are lacking. Methods: We analyzed long-term outcomes of Korean UC patients treated with adalimumab at the Asan Medical Center, Seoul, Korea. Results: Between July 2013 and Octo...

Cijeli opis

Bibliografski detalji

Glavni autori:	Eun Hye Oh, Jeongseok Kim, Namseok Ham, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
Format:	Artigo
Jezik:	Inglês
Izdano:	Gastroenterology Council for Gut and Liver 2020-05-01
Serija:	Gut and Liver
Teme:	colitis ulcerative adalimumab tumor necrosis factor-alpha prognosis
Online pristup:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl19137
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!